Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2023 Annual Meeting | ES2 - Emerging Science 2

Tuesday 04/25/23
05:30 PM - 07:00 PM EST Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Scientific Platform Session
Aging, Dementia, Cognitive, and Behavioral Neurology, Child Neurology and Developmental Neurology, Headache, Movement Disorders, Multiple Sclerosis, Neuromuscular and Clinical Neurophysiology (EMG), Neuro Trauma and Critical Care
Emerging Science presentations contain key aspects of research that are new and of sufficient scientific importance. These previously unpublished abstracts contain timely, significant, and innovative content.
1.50 CME credits

Program Materials Program Evaluations

Event Timeline
05:30 PM - 05:36 PM EST Abstract 001 - Holter of Movement Provides the First Digital Outcome Qualified by a Regulatory Agency
Laurent Servais
05:36 PM - 05:42 PM EST Abstract 002 - Interim Results from the NEXUS Open-Label Registration Study on the Safety and Efficacy of Leriglitazone in the Treatment of Childhood Cerebral Adrenoleukodystrophy
Eric James Mallack, MD
05:42 PM - 05:48 PM EST Abstract 003 - Expansion of an Intronic FGF14 GAA Short Tandem Repeat in Late-Onset Cerebellar Ataxia
David Pellerin, MD
05:48 PM - 05:54 PM EST Abstract 004 - Continuous Delivery of Levodopa/Carbidopa Using the Intra-Oral DopaFuse System: A Safety, Tolerability, PK and Efficacy Trial
C. Warren Olanow, MD
05:54 PM - 06:00 PM EST Abstract 005 - MOG-IgA characterizes a subgroup of patients with central nervous system demyelination
Anne-Katrin Proebstel, MD
06:00 PM - 06:06 PM EST Abstract 006 - Mitochondrial Dysfunction in Neuron-Derived Extracellular Vesicles and Brain Tissues of FXTAS Patients
Apostolos Manolopoulos, MD
06:06 PM - 06:12 PM EST Abstract 007 - Atogepant for the Preventive Treatment of Migraine Among Participants With Episodic Migraine With Prior Treatment Failure: Results From the ELEVATE Trial
Cristina Tassorelli
06:12 PM - 06:18 PM EST Abstract 008 - MEGAbIT: The role of magnetoencephalography in assessment and diagnosis in mild traumatic brain injury
Christopher Martin Allen, MBBS
06:18 PM - 06:24 PM EST Abstract 009 - ACHIEVE Trial, a Randomized, Placebo-Controlled, Multiple Ascending Dose Study of DYNE-101 in Individuals with Myotonic Dystrophy Type 1 (DM1)
Daniel Wolf, PhD
06:24 PM - 06:30 PM EST Abstract 010 - Teriflunomide (Aubagio) Extends The Time To Multiple Sclerosis In Radiologically Isolated Syndrome: The TERIS Study.
Christine Lebrun Frenay, MD, FAAN
06:30 PM - 07:00 PM EST Discussion Poster Q&A
Faculty Disclosures
Nicholas Elwood Johnson, MD, FAAN Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta Therapuetics. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne Therapeutics. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharma. Dr. Johnson has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for ML BIo . Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity. Dr. Johnson has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Arthex. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Juvena. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Entrada. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rgenta. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Angle Therapeutics. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AskBio. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Johnson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum. Dr. Johnson has stock in Angle Therapeutics. Dr. Johnson has stock in Juvena Therapeutics. The institution of Dr. Johnson has received research support from Novartis. The institution of Dr. Johnson has received research support from Takeda . The institution of Dr. Johnson has received research support from AMO Pharma. The institution of Dr. Johnson has received research support from Sarepta. The institution of Dr. Johnson has received research support from Dyne Therapeutics. The institution of Dr. Johnson has received research support from AskBio. The institution of Dr. Johnson has received research support from Pepgen. The institution of Dr. Johnson has received research support from ML Bio. The institution of Dr. Johnson has received research support from Vertex. The institution of Dr. Johnson has received research support from Arthex. Dr. Johnson has received intellectual property interests from a discovery or technology relating to health care.
Laurent Servais Laurent Servais has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Laurent Servais has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Laurent Servais has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. The institution of Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Evox. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Laurent Servais has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sysnav. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioHaven. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zentech. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MitoRx. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lupin. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fibrogen. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alltrana. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Illumina. Laurent Servais has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Laurent Servais has received research support from Roche. The institution of Laurent Servais has received research support from Novartis. The institution of Laurent Servais has received research support from Biogen. The institution of Laurent Servais has received research support from Zentech. The institution of Laurent Servais has received research support from BioHaven. The institution of Laurent Servais has received research support from PerkinHalmers. The institution of Laurent Servais has received research support from Scholar Rock.
Eric James Mallack, MD The institution of Dr. Mallack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Grace Science. The institution of Dr. Mallack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lysogene. Dr. Mallack has received research support from NINDS.
David Pellerin, MD Dr. Pellerin has nothing to disclose.
C. Warren Olanow, MD Dr. Olanow has received personal compensation for serving as an employee of Clintrex Research Corporation. Dr. Olanow has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Clintrex Research Corporation. Dr. Olanow has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Chevron/Syngenta. Dr. Olanow has stock in Clintrex Research Corporation.
Ana Beatriz Ayroza Galvao Ribeiro Gomes, MD Dr. Ayroza Galvao Ribeiro Gomes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Guidepoint. The institution of Dr. Ayroza Galvao Ribeiro Gomes has received research support from Roche.
Apostolos Manolopoulos, MD The institution of Dr. Manolopoulos has received research support from National Institute on Aging (NIA/NIH).
Patricia Pozo-Rosich, MD, PhD Dr. Pozo-Rosich has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Pozo-Rosich has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Pozo-Rosich has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Pozo-Rosich has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Pozo-Rosich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Pozo-Rosich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Pozo-Rosich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Pozo-Rosich has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly Foundation Spain. Dr. Pozo-Rosich has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sociedad Española Neurologia.
Christopher Martin Allen, MBBS The institution of Dr. Allen has received research support from National Institute for Health and Care Research (Research for Patient Benefit) [grant number PB-PG-0418-20044].
Daniel Wolf, PhD Dr. Wolf has received personal compensation for serving as an employee of Dyne Therapeutics. Dr. Wolf has received personal compensation for serving as an employee of Sarepta Therapeutics. Dr. Wolf has stock in Dyne Therapeutics. Dr. Wolf has stock in Sarepta Therapeutics.
Christine Lebrun Frenay, MD, FAAN Dr. Lebrun Frenay has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Revue Neurologique.
James J. Sejvar, MD, FAAN Dr. Sejvar has nothing to disclose.
Anne-Katrin Proebstel, MD The institution of Dr. Proebstel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Proebstel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Proebstel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Proebstel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Proebstel has received research support from Biogen. Dr. Proebstel has received intellectual property interests from a discovery or technology relating to health care.
Otto Rapalino, MD Dr. Rapalino has nothing to disclose.
Sandra Liliana Jimenez, MD Dr. Jimenez has nothing to disclose.
Caroline Sevin Caroline Sevin has nothing to disclose.
Juliana Ribeiro Constante, MD Ms. Constante has nothing to disclose.
Hendrik Rosewich, MD The institution of Prof. Rosewich has received research support from German Research Council. The institution of Prof. Rosewich has received research support from Eva Luise und Horst Köhler Stiftung.
Gloria Chiang The institution of Gloria Chiang has received research support from NIH/NIA. Gloria Chiang has received research support from Minoryx. Gloria Chiang has received personal compensation in the range of $500-$4,999 for serving as a Invited Speaker for CME with Horizons CME. Gloria Chiang has received personal compensation in the range of $5,000-$9,999 for serving as a Invited Speaker for CME with Efficient CME. Gloria Chiang has received personal compensation in the range of $500-$4,999 for serving as a Invited Speaker with Taiwan Neuroradiological Society. Gloria Chiang has received personal compensation in the range of $500-$4,999 for serving as a Invited Speaker with Chinese Society of Radiology.
Karl Gerard Helmer, PhD The institution of Dr. Helmer has received research support from Minoryx Therapeutics. The institution of Dr. Helmer has received research support from National Institute of Health.
Angeles Garcia-Cazorla, MD,PhD Dr. Garcia-Cazorla has nothing to disclose.
Elise Yazbeck, MD Dr. Yazbeck has nothing to disclose.
Laura Rodriguez-Pascau Laura Rodriguez-Pascau has received personal compensation for serving as an employee of Minoryx Therapeutics. Laura Rodriguez-Pascau has stock in Minoryx Therapeutics.
Patricia Musolino, MD, PhD Dr. Musolino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Minoryx Pharmaceuticals. Dr. Musolino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Altas Venture Capital. Dr. Musolino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Musolino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for IONIS Pharmaceuticals . Dr. Musolino has received research support from Minoryx Pharmaceuticals. Dr. Musolino has received research support from National Institute of Health-NINDS-R01. Dr. Musolino has received research support from Massachusetts General Hospital-ECOR. Dr. Musolino has received research support from Massachusetts General Hospital-Innovations Office. Dr. Musolino has received research support from National Institute of Health-NINDS-Admin Supp. K08. Dr. Musolino has received research support from Massachusetts General Hospital-Department of Neurology. Dr. Musolino has received research support from Dooley's Family Fund. Dr. Musolino has received publishing royalties from a publication relating to health care.
Maria Pascual, PhD Dr. Pascual has received personal compensation for serving as an employee of Minoryx.
Daniel Balentine Mr. Balentine has nothing to disclose.
Maria Rovira Masramon Ms. Rovira Masramon has nothing to disclose.
Pilar Pizcueta Pilar Pizcueta has received personal compensation for serving as an employee of Minoryx Therapeutics SL.
Guillem Pina Guillem Pina has received personal compensation for serving as an employee of Minoryx Therapeutics. Guillem Pina has stock in Minoryx Therapeutics.
Adriana Mantilla, MD,PhD Mrs. Mantilla has received personal compensation for serving as an employee of Minoryx Therapeutics.
Marco Emanuele, PhD Dr. Emanuele has nothing to disclose.
Silvia Pascual Silvia Pascual has received personal compensation for serving as an employee of Minoryx Therapeutics. Silvia Pascual has stock in Minoryx Therapeutics.
Arun Mistry, MD Dr. Mistry has received personal compensation for serving as an employee of Minoryx Therapeutics. Dr. Mistry has stock in Minoryx Therapeutics.
Marc Martinell Marc Martinell has received personal compensation for serving as an employee of Minoryx Therapeutics. Marc Martinell has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Minoryx Therapeutics. Marc Martinell has stock in Minoryx Therapeutics. Marc Martinell has received intellectual property interests from a discovery or technology relating to health care.
Anna Vila Brau, PhD Ms. Vila Brau has received personal compensation for serving as an employee of Minoryx Therapeutics. Ms. Vila Brau has stock in Minoryx Therapeutics.
Mathilde Renaud Mathilde Renaud has nothing to disclose.
Carlo Wilke, MD Dr. Wilke has nothing to disclose.
Sarah Fazal Ms. Fazal has nothing to disclose.
Matt Danzi Matt Danzi has nothing to disclose.
Marie-Josee Dicaire No disclosure on file
Carolin Kirsten Scriba, Other Ms. Scriba has received research support from the University of Western Australia. Ms. Scriba has received research support from the Australasian Genomic Technologies Association (AGTA).
Catherine Ashton, MBBS Dr. Ashton has nothing to disclose.
Laura Molina Porcel, MD,PhD Dr. Molina Porcel has nothing to disclose.
Sara Nagy, MD Dr. Nagy has nothing to disclose.
Atchayaram Nalini Atchayaram Nalini has nothing to disclose.
David Genis, Sr., MD Dr. GENIS has nothing to disclose.
Matthis Synofzik Matthis Synofzik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis Pharmaceuticals. Matthis Synofzik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. Matthis Synofzik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orphayzme Pharmaceuticals. The institution of Matthis Synofzik has received research support from EJPRD.
Phillipa Lamont, FRACP,PhD,MBBS Prof. Lamont has nothing to disclose.
Bernard Brais, MD Dr. Brais has nothing to disclose.
Antoine Duquette, MD Dr. Duquette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Reata. The institution of Dr. Duquette has received research support from Actelion. The institution of Dr. Duquette has received research support from Ataxia Canada/FARA.
Henry Houlden Henry Houlden has nothing to disclose.
Ludger Schols, MD Dr. Schols has received personal compensation in the range of $500-$4,999 for serving as a Consultant for VICO Therapeutics. Dr. Schols has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Schols has received research support from Vigil.
Gianina Ravenscroft, PhD Dr. Ravenscroft has nothing to disclose.
Stephan Zuchner, MD, FAAN Dr. Zuchner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Zuchner has received research support from Muscular Dystrophy Association. The institution of Dr. Zuchner has received research support from CMT Association. Dr. Zuchner has received intellectual property interests from a discovery or technology relating to health care.
Roberta La Piana Roberta La Piana has nothing to disclose.
Nigel G. Laing Nigel G. Laing has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elslevier. The institution of Nigel G. Laing has received research support from Australian National Health and Medical Research Council. The institution of Nigel G. Laing has received research support from Australian Medical Research Future Fund. Nigel G. Laing has received publishing royalties from a publication relating to health care.
Kym Boycott The institution of Kym Boycott has received research support from Genome Canada. The institution of Kym Boycott has received research support from CIHR.
Deborah J. McIntyre, MD Dr. McIntyre has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck & Roche pharmaceuticals. Dr. McIntyre has received personal compensation in the range of $50,000-$99,999 for serving as a employed physician scientist with Luxembourg Institute of Health.
Rejko Krueger Rejko Krueger has nothing to disclose.
Michele Matarazzo, MD Dr. Matarazzo has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Parkinson and Movement Disorders Society.
Jose A. Obeso, MD No disclosure on file
Andrew J. McGarry, MD Dr. McGarry has nothing to disclose.
Fabrizio Stocchi Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bial, Biogen, Sunovion, Lundbeck, UCB, Zambon, Chiesi, Lusofarmaco, Abbvie, Neuroderm, Kyowa, Synegile, Roche, Britannia, Sunovion, Blue Rock. Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIAL, Zambon, Biogen, Roche, Synegile, Sunovion. Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bial, Zambon, UCB, Kyowa, Sunovion.
Nuria Cerda-Fuertes, MD Ms. Cerda-Fuertes has nothing to disclose.
Laila Kulsvehagen Mrs. Kulsvehagen has nothing to disclose.
Patrick Lipps Mr. Lipps has nothing to disclose.
Alessandro Cagol, MD Dr. Cagol has nothing to disclose.
Tradite Neziraj, MD Dr. Neziraj has nothing to disclose.
Anne-Catherine Lecourt Anne-Catherine Lecourt has nothing to disclose.
Jasmine Lerner Ms. Lerner has nothing to disclose.
Julia Flammer, MD Mrs. Flammer has nothing to disclose.
Thivya Pakeerathan Miss Pakeerathan has nothing to disclose.
Mario Luiz Ribeiro Monteiro, MD Prof. MONTEIRO has nothing to disclose.
Aline de Moura Brasil Matos, MD The institution of Dr. Matos has received research support from Hoffmann LaRoche.
Nina De Oliveira Soares Siebenbor, MD Dr. De Oliveira Soares Siebenbor has received personal compensation for serving as an employee of MIAC AG Basel.
Clarissa Dos Reis Pereira, MD Miss PEREIRA has received research support from CAPES - Coordenação de Aperfeiçoamento de Nível Superior, Brasília, Brazil, and CNPq- Conselho Nacional de Desenvolvimento Científico e Tecnológico, (No 308172/2018-3), Brasília, Brazil..
Vinicius Andreoli Schoeps, MD Dr. Schoeps has nothing to disclose.
Carolin Schwake, MD Mrs. Schwake has nothing to disclose.
Claudia Chien The institution of Claudia Chien has received research support from Novartis. The institution of Claudia Chien has received research support from Alexion. Claudia Chien has a non-compensated relationship as a Standing Committee on Science Member with Canadian Institutes for Health Research that is relevant to AAN interests or activities.
Rosa Cortese No disclosure on file
Ruth Schneider Ruth Schneider has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche Pharma AG. Ruth Schneider has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Alexion Pharma.
Samira Apostolos-Pereira Samira Apostolos-Pereira has nothing to disclose.
Sabine Schaedelin Sabine Schaedelin has nothing to disclose.
Patrick Schindler, MD Dr. Schindler has nothing to disclose.
Natalia Trombini Mendes, MD Dr. Mendes has nothing to disclose.
Orhan Aktas, MD Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Aktas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Aktas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Horizon. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Aktas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Aktas has received research support from German Research Foundation. The institution of Dr. Aktas has received research support from German Ministry of Science. The institution of Dr. Aktas has received research support from Neuromyelitis optica Study Group (NEMOS).
Matthias Mehling, MD The institution of Dr. Mehling has received research support from Swiss National Science Foundation. The institution of Dr. Mehling has received research support from Roche. The institution of Dr. Mehling has received research support from Merck.
Urs Martin Fischer, MD, PA The institution of Urs Fischer has received research support from Medtronic. The institution of Urs Fischer has received research support from Medtronic.
Tobias Derfuss An immediate family member of Tobias Derfuss has received personal compensation for serving as an employee of Novartis. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. The institution of Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Tobias Derfuss has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GeNeuro. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MedDay. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Merck. Tobias Derfuss has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Roche. An immediate family member of Tobias Derfuss has received stock or an ownership interest from Novartis. The institution of Tobias Derfuss has received research support from Roche. The institution of Tobias Derfuss has received research support from Biogen.
Marius Ringelstein Marius Ringelstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Marius Ringelstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Ilya *use 181355 Ayzenberg No disclosure on file
Friedemann Paul The institution of Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe PC (MTPC). The institution of Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aarhus University. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Paul has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CELGENE. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ACRELION. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Viela Bio. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizter. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. The institution of Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer.
Ludwig Kappos, MD, FAAN The institution of Dr. Kappos has received research support from Bayer. The institution of Dr. Kappos has received research support from Biogen. The institution of Dr. Kappos has received research support from Genentech. The institution of Dr. Kappos has received research support from Genzyme. The institution of Dr. Kappos has received research support from Janssen. The institution of Dr. Kappos has received research support from Merck Serono. The institution of Dr. Kappos has received research support from Minoryx. The institution of Dr. Kappos has received research support from Novartis. The institution of Dr. Kappos has received research support from Roche. The institution of Dr. Kappos has received research support from Sanofi. The institution of Dr. Kappos has received research support from Santhera. The institution of Dr. Kappos has received research support from Swiss MS Society, Swiss National Research Foundation, European Union, Roche Research Foundation, Innosuisse. The institution of Dr. Kappos has received research support from Shionogi. The institution of Dr. Kappos has received research support from Japan Tobacco. The institution of Dr. Kappos has received research support from Auriga Vision AG. The institution of Dr. Kappos has received research support from EMD Serono. The institution of Dr. Kappos has received research support from Glaxo Smith Kline. The institution of Dr. Kappos has received research support from Wellmera AG. The institution of Dr. Kappos has received research support from Eli Lilly (Suisse) SA. The institution of Dr. Kappos has received research support from Bristol Myers Squibb. The institution of Dr. Kappos has received research support from Celltrion Inc. Dr. Kappos has received intellectual property interests from a discovery or technology relating to health care.
Dagoberto Callegaro, Sr. Dr. Callegaro has nothing to disclose.
Cristina Granziera, MD, PhD Dr. Granziera has nothing to disclose.
Athina Papadopoulou, MD The institution of Dr. Papadopoulou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck Schweiz AG. The institution of Dr. Papadopoulou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie AG. The institution of Dr. Papadopoulou has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lilly. The institution of Dr. Papadopoulou has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Papadopoulou has received research support from Freie Akademische Gesellschaft Basel . Dr. Papadopoulou has received personal compensation in the range of $500-$4,999 for serving as a Travel Support (for Congress) with Eli Lilly. Dr. Papadopoulou has received personal compensation in the range of $500-$4,999 for serving as a Travel support (for Congress) with TEVA.
Jens Kuhle, MD Dr. Kuhle has nothing to disclose.
Pamela J. Yao, PhD Dr. Yao has nothing to disclose.
David Hessl The institution of Prof. Hessl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zynerba Pharmaceuticals. The institution of Prof. Hessl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tetra Therapeutics. The institution of Prof. Hessl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Healx.
Susan M. Rivera, PhD The institution of Dr. Rivera has received research support from National Institutes of Health. Dr. Rivera has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH. Dr. Rivera has received personal compensation in the range of $0-$499 for serving as a Public Member of Interagency Autism Coordinating Committee with U.S. Department of Health and Human Services .
Flora Tassone Flora Tassone has nothing to disclose.
Dimitrios Kapogiannis, MD The institution of Dr. Kapogiannis has received research support from National Institute on Aging (NIA/NIH).
Veronica Martinez Cerdeno, PhD Dr. Martinez Cerdeno has nothing to disclose.
Randi Hagerman Randi Hagerman has received publishing royalties from a publication relating to health care.
Cristina Tassorelli Cristina Tassorelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Cristina Tassorelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dompè. Cristina Tassorelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Cristina Tassorelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Cristina Tassorelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. The institution of Cristina Tassorelli has received research support from Abbvie.
Hua Guo, PhD Hua Guo has received personal compensation for serving as an employee of AbbVie. Hua Guo has received stock or an ownership interest from AbbVie.
Michel Lanteri-Minet, MD Dr. Lanteri-Minet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Lanteri-Minet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Lanteri-Minet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Lanteri-Minet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Lanteri-Minet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. The institution of Dr. Lanteri-Minet has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Medtronic. Dr. Lanteri-Minet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TEVA. Dr. Lanteri-Minet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UPSA. Dr. Lanteri-Minet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IPSEN. Dr. Lanteri-Minet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. The institution of Dr. Lanteri-Minet has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Pfizer. Dr. Lanteri-Minet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Savia BioElectronics. Dr. Lanteri-Minet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ReckittBenckiser. The institution of Dr. Lanteri-Minet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon. Dr. Lanteri-Minet has received publishing royalties from a publication relating to health care.
Joel M. Trugman, MD, FAAN Dr. Trugman has received personal compensation for serving as an employee of AbbVie. Dr. Trugman has stock in AbbVie.
Sara E. Sacco, MD The institution of Dr. Sacco has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie/Allergan. The institution of Dr. Sacco has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. The institution of Dr. Sacco has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Sacco has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Impel Neuropharma. The institution of Dr. Sacco has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TEVA. The institution of Dr. Sacco has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI (Now Collegium). The institution of Dr. Sacco has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/Abbvie. The institution of Dr. Sacco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Sacco has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. The institution of Dr. Sacco has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly. The institution of Dr. Sacco has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Impel NeuroPharma. Dr. Sacco has received personal compensation in the range of $10,000-$49,999 for serving as a Key Opinion Leader with Teva.
Tomas Nezadal, PhD Dr. Nezadal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Nezadal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Nezadal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Nezadal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Nezadal has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Dr. Nezadal has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for endowment fund Hedalga.
Rosa Liliana De Abreu Ferreira, MD Dr. De Abreu Ferreira has received personal compensation for serving as an employee of AbbVie. Dr. De Abreu Ferreira has stock in AbbVie.
Michelle Finnegan Michelle Finnegan has received personal compensation for serving as an employee of AbbVie.
Krisztian Nagy, MD Dr. Nagy has received personal compensation for serving as an employee of AbbVie. Dr. Nagy has stock in AbbVie.
Lukas Rier, PhD Dr. Rier has nothing to disclose.
Roshan Das Nair Roshan Das Nair has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Roshan Das Nair has received research support from MS Society. The institution of Roshan Das Nair has received research support from NIHR. The institution of Roshan Das Nair has received research support from MRC. The institution of Roshan Das Nair has received research support from Stroke Association. Roshan Das Nair has received publishing royalties from a publication relating to health care. Roshan Das Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Chair of RfPB RAC East Midlands with NIHR.
Matthew Jon Brookes, PhD No disclosure on file
Lauren Elizabeth Gascoyne, PhD Dr. Gascoyne has nothing to disclose.
Rob Dineen The institution of Rob Dineen, 8063 has received research support from UK National Institute of Health Research.
Nikolaos Evangelou, PhD Dr. Evangelou has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis . Dr. Evangelou has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis . The institution of Dr. Evangelou has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Roche. Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck . Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen . Dr. Evangelou has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for UK crown prosecution service. Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis .
Chris Mix, MD Dr. Mix has received personal compensation for serving as an employee of Dyne Therapeutics. Dr. Mix has stock in Dyne Therapeutics.
Lydiane Mondot Lydiane Mondot has nothing to disclose.
Wildon Farwell, MD Dr. Farwell has received personal compensation for serving as an employee of Biogen. Dr. Farwell has received stock or an ownership interest from Biogen.
Cassandre Landes-Chateau, PhD Mrs. Landes-Chateau has received research support from University Cote d'Azur.
Pierre Labauge, MD Dr. Labauge has nothing to disclose.
Patrick Vermersch Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS-Celgene. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for La revue des microbiotes. The institution of Patrick Vermersch has received research support from Roche. The institution of Patrick Vermersch has received research support from Sanofi.
Ashish Dugar, PhD Dr. Dugar has received personal compensation for serving as an employee of Dyne Therapeutics.
Aksel Siva, MD Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abdi Ibrahim Ilac - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono . The institution of Dr. Siva has received research support from Turkish MS Society. The institution of Dr. Siva has received research support from The Scientific and Technological Research Council Of Turkey - Health Sciences Research Grants.
Eric Thouvenot, MD, PhD Dr. Thouvenot has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biologix FZCo.. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HEALTHME. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Thouvenot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Thouvenot has received research support from Biogen. The institution of Dr. Thouvenot has received research support from Novartis. The institution of Dr. Thouvenot has received research support from Roche.
Maria Pia Sormani Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Geneuro. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic. Maria Pia Sormani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medday. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Baoguang Han No disclosure on file
Caroline Papeix Caroline Papeix has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIOGEN . Caroline Papeix has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE . Caroline Papeix has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK. Caroline Papeix has received personal compensation in the range of $0-$499 for serving as a Consultant for NOVARTIS .
Murat Terzi, PhD Dr. Terzi has nothing to disclose.
Francoise Durand Dubief The institution of Francoise Durand Dubief has received research support from ARSEP.
Nathalie Derache Nathalie Derache has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK. Nathalie Derache has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK. Nathalie Derache has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS.
Husnu Efendi, MD The institution of Dr. Efendi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alexion. The institution of Dr. Efendi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. The institution of Dr. Efendi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Roche. The institution of Dr. Efendi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Novartis.
Bertrand Bourre Bertrand Bourre has nothing to disclose.
Emmanuelle Le Page Emmanuelle Le Page has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK. Emmanuelle Le Page has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Robert Hoepner Robert Hoepner has nothing to disclose.
Jonathan Ciron, MD Jonathan Ciron, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Jonathan Ciron, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Jonathan Ciron, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Jonathan Ciron, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS - Celgene. Jonathan Ciron, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Sandrine Wiertlewski Sandrine Wiertlewski has received personal compensation in the range of $0-$499 for serving as a Consultant for SANOFI. Sandrine Wiertlewski has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Sandrine Wiertlewski has received personal compensation in the range of $0-$499 for serving as a Consultant for NOVARTIS. Sandrine Wiertlewski has received personal compensation in the range of $0-$499 for serving as a Consultant for ALEXION. Sandrine Wiertlewski has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Sandrine Wiertlewski has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK.
Rana Karabudak, MD Dr. Karabudak has nothing to disclose.
Jerome De Seze Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma.
Pierre Clavelou, MD,PhD Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Clavelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Christina Azevedo, MD, FAAN Dr. Azevedo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi Genzyme. Dr. Azevedo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Azevedo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Azevedo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Azevedo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. Azevedo has received research support from National Multiple Sclerosis Society. The institution of Dr. Azevedo has received research support from National Institutes of Health/National Institutes of Neurological Disorders and Stroke. The institution of Dr. Azevedo has received research support from National Multiple Sclerosis Society.
Orhun H. Kantarci, MD Dr. Kantarci has nothing to disclose.
Mikael Cohen Mikael Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Roche, Merck, Ad scientiam, Novartis, Alexion, BMS.
Darin T. Okuda, MD, FAAN Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Celgene. Dr. Okuda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for VielaBio.
Omer Faruk Turan, MD Dr. Turan has nothing to disclose.
Nur *Use 170196 Yuceyar No disclosure on file
Francesca Bovis Francesca Bovis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Francesca Bovis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen.
Daniel Pelletier, MD Dr. Pelletier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Pelletier has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Pelletier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Pelletier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Polpharma Biologics.